Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
BMX-001 as a Radio-Protector in Head and Neck Cancer Therapy Phase I and Phase II
Administered By
Radiation Oncology
Awarded By
BioMimetix Pharmaceutical, Inc.
Contributors
Brizel, David Manfield
Principal Investigator
Start/End
March 1, 2017 - May 8, 2022